Home
Live Updates
LogicBio Therapeutics Announces Upcoming Presentations on GeneRide Development Candidate and Multiple Advancements in AAV Manufacturing Processes at ASGCT Annual Meeting : vimarsana.com
LogicBio Therapeutics Announces Upcoming Presentations on GeneRide Development Candidate and Multiple Advancements in AAV Manufacturing Processes at ASGCT Annual Meeting
/PRNewswire/ -- LogicBio® Therapeutics, Inc. (Nasdaq: LOGC), a clinical-stage genetic medicine company, today announced that it will present four abstracts...
Related Keywords
Washington ,
United States ,
William Lee ,
Stephen Jasper ,
Adam Daley ,
Chih Wei Ko ,
Jing Liao ,
Nick Digioia ,
Prnewswire Logicbio ,
American Society Of Gene Cell Therapy ,
Logicbio Therapeutics Inc ,
Nasdaq ,
Exchange Commission ,
Development Or Manufacturing ,
Therapeutics Inc ,
Gilmartin Group ,
Berry Company Public Relations ,
American Society ,
Cell Therapy ,
Presentation Title ,
Accommodate Increased Upstream Yield ,
Reduce Manufacturing ,
Vector Manufacturing ,
Next Generation ,
Advanced Plasmid Design ,
Transfection Reagent ,
Achieves High Yield ,
Scalable Suspension ,
Improving Vector Design ,
Tyrosinemia Type ,
Proof Of Concept Studies ,
Comprehensive Potency Assay Matrix ,
Late Stage Manufacturing ,
Vector Product Engineering ,
Logicbio Therapeutics ,
Private Securities Litigation Reform Act ,
Annual Report ,
Bio Therapeutics ,
Nc ,
vimarsana.com © 2020. All Rights Reserved.